spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  chronic pain 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 5 Jun 2026
Neuronoff Implants First Patient in DOD-Funded Trial of Injectrode(R) for Neurogenic Bladder in Spinal Cord Injury
Devices Urology
 HSMN NewsFeed - 4 Feb 2026
Stratus Medical Raises $10 million Series B to Complete Development of New Technology and Fund Clinical Trial
Devices Venture Capital
 HSMN NewsFeed - 12 Nov 2025
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
Devices Neurology Venture Capital
 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Oct 2025
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2025
Amber Implants Secures FDA 510(k) Clearance for VCFix(R) Spinal System: A Next-Generation Solution for Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 11 Aug 2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Jul 2025
Neuros Medical Secures $56M Series D to Commercialize the Altius(R) System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Devices Venture Capital
 HSMN NewsFeed - 26 Jun 2025
Avivomed Names Dan Brounstein as Next Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Mar 2025
Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
Devices Neurology Venture Capital
 HSMN NewsFeed - 12 Nov 2024
Nevro's HFX iQ(TM) Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Devices Regulatory
 HSMN NewsFeed - 22 Aug 2024
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
Devices Distribution
 HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2023
Medtronic receives CE Mark approval for Inceptiv(TM) spinal cord stimulator with closed-loop sensing to treat chronic pain
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 7 Aug 2023
NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Apr 2023
Neuspera Medical(R) Announces FDA Clearance of its System for Peripheral Nerve Stimulation
Devices Neurology FDA
 HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Devices Neurology FDA
 HSMN NewsFeed - 19 Dec 2022
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
Devices FDA Product Launch
 HSMN NewsFeed - 2 Dec 2022
PainTEQ Expands Leadership Team with New Senior VP of Reimbursement and Market Access
Devices Personnel
 HSMN NewsFeed - 26 Oct 2022
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife(R) System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
Devices Reimbursement
 HSMN NewsFeed - 1 Sep 2022
Nevro Announces Multiple Positive Coverage Updates for the Treatment of Painful Diabetic Neuropathy
Devices Reimbursement
 HSMN NewsFeed - 31 Aug 2022
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 5 Jul 2022
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy
Devices Neurology
 HSMN NewsFeed - 23 Jun 2022
Tryp Therapeutics Appoints New Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 May 2022
Tryp Therapeutics Strengthens Board of Directors with Appointment of Chris Ntoumenopoulos as Independent Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2022
ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 May 2022
Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 6 Apr 2022
FDA approves Novartis Vijoice(R) (alpelisib) as first and only treatment for select patients with PIK3CA-Related Overgrowth Spectrum (PROS)
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Mar 2022
10-Year Data Shows Accuray CyberKnife(R) System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
Devices Oncology
 HSMN NewsFeed - 15 Mar 2022
PainTEQ Appoints Two New Vice Presidents
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 8 Mar 2022
Electromedical Announces Addition of David Orn as Director of Business and Sales Development
Devices Personnel
 HSMN NewsFeed - 23 Feb 2022
Abilita Bio Appoints Dan Bradbury to its Newly Formed Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2022
Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine
Devices Neurosurgery
 HSMN NewsFeed - 4 Jan 2022
Abbott's Proclaim(TM) XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.
Devices Neurology Radiology FDA
 HSMN NewsFeed - 23 Nov 2021
Smith & Nephew Launches 'Turn-Key' Robotic-Assisted Surgical System; Designed to Quickly Augment the Orthopaedic Team's Skills Set for Greater Accuracy(1-3)¥, Improved Outcomes(4), and Potentially an Immediate Scalable Solution to NHS
Devices Orthopaedic Surgery Product Launch
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2021
Michael Enxing Appointed President of PainTEQ
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 30 Sep 2021
Electromedical Technologies Receives Key Medical Device Certification
Devices Regulatory
 HSMN NewsFeed - 19 Jul 2021
Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 23 Jun 2021
Stratus(TM) Medical receives CE Mark for Nimbus(R) RF Multitined Expandable Electrode and Vesta(TM) RF Cannula
Devices Regulatory
 HSMN NewsFeed - 24 May 2021
Eliem Therapeutics Announces $60 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 19 May 2021
SoftWave Tissue Regeneration Technologies Receives FDA Clearance for Blood Circulation Increase, Minor Aches and Pains Relief and Connective Tissue Activation
Devices FDA
 HSMN NewsFeed - 27 Apr 2021
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 19 Apr 2021
Nevro Appoints Jon R. Shear as Vice President, Corporate Development
Devices Personnel
 HSMN NewsFeed - 9 Apr 2021
NeuX Technologies Announces Dr. John Pecora as Vice President of Business Development
Devices Personnel
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 28 Jan 2021
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Jan 2021
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
Devices Neurology Venture Capital
 HSMN NewsFeed - 14 Jan 2021
Abbott to Launch the NeuroSphere(TM) myPath(TM) Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Devices Neurology Monitoring Product Launch
 HSMN NewsFeed - 4 Jan 2021
Flowonix Medical, Inc. and SWK Holdings Corporation Announce Closing of $33 Million Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 4 Jan 2021
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery
 HSMN NewsFeed - 3 Sep 2020
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Devices Venture Capital
 HSMN NewsFeed - 2 Sep 2020
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Jul 2020
Stratus(TM) Medical announces FDA 510k clearance for the Vesta(TM) RF Cannula to expand product portfolio and the first Vesta patient treatments in the United States
Devices FDA
 HSMN NewsFeed - 23 Jul 2020
Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Devices Neurology FDA
 HSMN NewsFeed - 7 Jul 2020
NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield
Devices Distribution
 HSMN NewsFeed - 9 Jun 2020
Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer
Devices Neurology Personnel
 HSMN NewsFeed - 4 Jun 2020
Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 16 Apr 2020
Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 28 Feb 2020
Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction
Devices Neurology Litigation
 HSMN NewsFeed - 28 Feb 2020
Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S.
Devices Neurology Litigation
 HSMN NewsFeed - 27 Jan 2020
Biofourmis Names Pharma and Tech Veterans as COO and CTO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2020
Soin Neuroscience Develops A New Spinal Cord Stimulator to Treat Chronic Pain
Devices Neurology
 HSMN NewsFeed - 20 Jan 2020
Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality
Devices Neurology Personnel
 HSMN NewsFeed - 18 Dec 2019
Nevro Appoints Karen N. Prange to the Company's Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 5 Nov 2019
Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 1 Oct 2019
Nektar Announces Key Executive Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Sep 2019
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 16 Sep 2019
Saluda Medical Announces European Commercial Launch of Evoke(R), the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief
Devices Regulatory Product Launch
 HSMN NewsFeed - 22 Aug 2019
Biofourmis Names Two Pharmaceutical Veterans to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jul 2019
Alfa Plus by Solio Receives FDA Clearance: Unique Device Delivers Pain Relief Without Pharmaceuticals
Devices FDA Product Launch
 HSMN NewsFeed - 25 Jul 2019
Nevro Announces Court Order Granting Preliminary Injunction Against Stimwave Technologies, Inc.
Devices Litigation
 HSMN NewsFeed - 17 Jul 2019
FDA Clears Erchonia's FX 635 for Relief of Chronic Musculoskeletal Pain
Devices FDA
 HSMN NewsFeed - 28 Jun 2019
Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
Biopharmaceuticals Generics Distribution Product Launch
 HSMN NewsFeed - 25 Jun 2019
Nevro Announces Executive Appointments
Devices Personnel
 HSMN NewsFeed - 3 Jun 2019
Saluda Medical Announces Clinical Study Results for Evoke(R) ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
Devices Neurosurgery
 HSMN NewsFeed - 28 May 2019
Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 May 2019
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 May 2019
Nektar Announces the Launch of Inheris Biopharma, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2019
Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2019
Lannett Enters Into Distribution Agreement For Generic Adderall(R)
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 4 Mar 2019
COOLIEF* Cooled Radiofrequency Achieves Statistically Significant Reductions in Pain and Improved Function Compared to Hyaluronic Acid Injection
Devices Orthopaedic
 HSMN NewsFeed - 19 Feb 2019
Bioness StimRouter(R) Neuromodulation System Receives European CE Mark Approval for the Treatment of Overactive Bladder (OAB)
Devices Neurology Urology Regulatory
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 15 Feb 2019
Nevro Files Lawsuit for Patent Infringement Against Stimwave in the U.S.
Devices Neurology Litigation
 HSMN NewsFeed - 10 Jan 2019
Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2018
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Devices Neurology FDA Regulatory Product Launch
 HSMN NewsFeed - 14 Nov 2018
Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Oct 2018
FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain
Devices Drug Delivery Neurology FDA
 HSMN NewsFeed - 12 Oct 2018
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2018
SI-BONE, Inc. Announces that NICE, the UK National Institute for Health and Care Excellence, Published Medical Technology Guidance Finding that the Evidence Supports Treatment of Sacroiliac Joint Pain with the iFuse Implant System(R)
Devices Orthopaedic Neurosurgery Regulatory
 HSMN NewsFeed - 6 Sep 2018
SiteOne Therapeutics Appoints John Hunter, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2018
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA(TM) (lofexidine) 0.18 Mg Tablets
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 30 Jul 2018
Nevro Announces Patent Litigation Update
Devices Neurology Litigation
 HSMN NewsFeed - 25 Jul 2018
Nevro Announces Patent Litigation Update
Devices Neurology Litigation
 HSMN NewsFeed - 20 Mar 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Mar 2018
Pharmaceutical Startup, Bridge Therapeutics, Announces Tim Peara Will Be Joining the Company as the Director of Finance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Mar 2018
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
Diagnostics Product Launch
 HSMN NewsFeed - 7 Mar 2018
New Medical Policy Makes the Bioness StimRouter(R) Neuromodulation System a Covered Benefit for Highmark Blue Cross Blue Shield Policy Holders
Devices Neurology Reimbursement
 HSMN NewsFeed - 21 Feb 2018
Pharmaceutical Startup, Bridge Therapeutics, Names David H. Bergstrom, Ph.D. as New Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Feb 2018
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2018
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System
Devices Neurology Regulatory
 HSMN NewsFeed - 29 Jan 2018
Study Shows CyberKnife(R) System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia Patients
Devices Neurosurgery Neurology
 HSMN NewsFeed - 12 Jan 2018
Boston Scientific Announces Positive Results from WHISPER Spinal Cord Stimulation Study
Devices Neurology
 HSMN NewsFeed - 11 Jan 2018
Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter(TM) Spinal Cord Stimulator System
Devices Neurology FDA
 HSMN NewsFeed - 8 Jan 2018
Nevro Receives FDA Approval for Senza II(TM) Spinal Cord Stimulation System Delivering HF10(TM) Therapy
Devices FDA
 HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Dec 2017
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
Devices Neurology Reimbursement
 HSMN NewsFeed - 22 Nov 2017
Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 9 Oct 2017
SI-BONE, Inc. Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure(TM) for Minimally Invasive SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 18 Sep 2017
Halyard Health Announces New Data Supporting COOLIEF* Cooled RF for the Treatment of Chronic Osteoarthritis Knee Pain
Devices Orthopaedic
 HSMN NewsFeed - 23 Aug 2017
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Aug 2017
AVACEN Medical Receives CE (Conformité Européenne) Mark for Increasing Microcirculation and Treating Widespread Fibromyalgia Pain
Devices Regulatory
 HSMN NewsFeed - 25 Jul 2017
Early Treatment Is Revolutionizing Outcome Of Burn Scars
Devices Dermatology
 HSMN NewsFeed - 12 Jul 2017
BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA(R) In Canada
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 30 May 2017
Saluda Medical Secures AU$53 Million in Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 10 May 2017
Bioness and Ottobock Announce Strategic European Distribution Partnership
Devices Distribution
 HSMN NewsFeed - 10 Apr 2017
Non-Opioid Drug Development Firm, CerSci Therapeutics, Announces Appointment of Pharma Leaders Pat Confalone and Perry Molinoff to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2017
Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Mar 2017
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Jan 2017
Adynxx Announces Closing of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jan 2017
Abbott Completes the Acquisition of St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2016
Grünenthal Receives Breakthrough Therapy Designation From U.S. FDA for Neridronic Acid for the Treatment of CRPS
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Dec 2016
Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Dec 2016
St. Jude Medical Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulation System
Devices Neurology Regulatory
 HSMN NewsFeed - 29 Nov 2016
Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S.
Devices Neurology Litigation
 HSMN NewsFeed - 14 Nov 2016
St. Jude Medical Announces Full-Body MRI Compatibility and Second Major Upgrade for Proclaim Elite Spinal Cord Stimulation System
Devices Neurology Radiology FDA Product Launch
 HSMN NewsFeed - 9 Nov 2016
Sorrento Therapeutics Closes Acquisition of Scilex
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2016
Lexicon Pharmaceuticals Acquires Exclusive Rights To Development Candidate For Neuropathic Pain From Its Alliance With Bristol-Myers Squibb
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Nov 2016
The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder
Diagnostics Personalized Medicine
 HSMN NewsFeed - 24 Oct 2016
aTyr Pharma Receives FDA Fast Track Designation for Resolaris(TM) to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Sep 2016
Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10(TM) Therapy over Traditional Spinal Cord Stimulation for Chronic Pain
Devices Neurology
 HSMN NewsFeed - 29 Aug 2016
Elite Announces Development and License Agreement with SunGen Pharma LLC
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 27 Jul 2016
Boston Scientific Announces Acquisition of Cosman Medical
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 21 Jun 2016
Keryx Biopharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2016
Collegium Announces Election of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Jun 2016
Merck to Acquire Afferent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 May 2016
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2016
Boston Scientific Receives U.S. FDA Approval for Precision Montage(TM) MRI Spinal Cord Stimulator System
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 9 May 2016
Elite Pharmaceuticals to Present SequestOx(TM) Data at the American Pain Society 35th Annual Scientific Meeting
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 May 2016
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2016
Abbott to Acquire St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 12 Apr 2016
Elite Pharmaceuticals Announces Changes to their Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2016
St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy
Devices Neurology Product Launch
 HSMN NewsFeed - 5 Apr 2016
Braeburn Pharmaceuticals and Camurus Announce Enrollment Goals Reached in Two Pivotal Phase 3 Trials of Cam2038 for Treatment of Opioid Dependence
Biopharmaceuticals
 HSMN NewsFeed - 29 Mar 2016
Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Mar 2016
Elite Announces U.S. FDA Priority Review Designation for SequestOx(TM) NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2016
Ember Therapeutics Enhances Regenerative Medicine Pipeline With Acquisition of ICX-RHY/Vavelta(TM) from Intercytex
Regenerative Medicine Dermatology Acquisitions
 HSMN NewsFeed - 29 Feb 2016
Egalet Announces FDA Acceptance of New Drug Application for ARYMO(TM) ER (Morphine Sulfate) Extended-Release Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 16 Feb 2016
Nutra Pharma Announces Management Expansion and Business Updates
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2016
Maquet Medical Systems USA, A Getinge Group Company Announces Partnership with BIOTRONIK to Distribute Endovascular Medical Devices in United States
Devices Interventional Distribution
 HSMN NewsFeed - 2 Feb 2016
Collegium Provides Litigation Update
Biopharmaceuticals Litigation
 HSMN NewsFeed - 1 Feb 2016
Bioness Announces the Publication of StimRouter(TM) Neuromodulation System Clinical Trial
Devices Neurology
 HSMN NewsFeed - 19 Jan 2016
Abide Therapeutics Appoints Richard N. Kender to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2016
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2016
ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Nov 2015
St. Jude Medical Announces European Launch of the World’s First and Only Upgradeable, Non-Rechargeable, Burst-Enabled MR-Conditional SCS System
Devices Neurology Product Launch
 HSMN NewsFeed - 19 Nov 2015
St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option
Devices Neurology FDA
 HSMN NewsFeed - 9 Nov 2015
Collegium Announces FDA Tentative Approval for Xtampza(TM) ER, a Novel Abuse-Deterrent Analgesic for Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Oct 2015
Heron Therapeutics Appoints Neil J. Clendeninn, M.D., Ph.D. as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2015
Quartet Medicine Completes $23.25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Sep 2015
Bioness Announces First Commercial Procedure of StimRouter(TM) Neuromodulation System
Devices Neurology Product Launch
 HSMN NewsFeed - 9 Sep 2015
St. Jude Medical Announces Leadership Transition Plan
Devices Cardiology Neurology Personnel
 HSMN NewsFeed - 31 Aug 2015
Flowonix Medical, Inc. Announces First Use of Its Patient Therapy Controller (PTC(TM))
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 24 Aug 2015
St. Jude Medical Receives CE Mark for Industry's Only MR-Conditional Rechargeable Spinal Cord Stimulator Approved to Offer Burst Stimulation
Devices Neurology Regulatory
 HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 7 Aug 2015
Flowonix Medical Inc. Announces FDA Approval of New Product
Devices Drug Delivery FDA
 HSMN NewsFeed - 20 Jul 2015
St. Jude Medical Announces FDA Approval for Industry's Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 16 Jul 2015
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2015
St. Jude Medical Completes Acquisition of Spinal Modulation, Inc.
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2015
St. Jude Medical Receives FDA Approval for the World’s Smallest Upgradeable MR-Conditional Spinal Cord Stimulation System
Devices Neurology FDA
 HSMN NewsFeed - 1 Apr 2015
Iroko Pharmaceuticals Appoints New Member to Company’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2015
Bioness Initiates Pilot Study of StimRouter(TM) Neuromodulation System for Overactive Bladder (OAB)
Devices Urology
 HSMN NewsFeed - 19 Mar 2015
Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2014
Elite Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2014
Quartet Medicine Launches with $17 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Sep 2014
Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2014
Trevena Appoints Adam M. Koppel to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2014
ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2014
NeuroMetrix Reports Japan Regulatory Approval for NC-stat DPNCheck
Devices Regulatory
 HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 4 Apr 2014
Via Surgical Ltd. Receives FDA Clearance to Commercialize FasTouch(TM), the First Suture-Like Mesh Fixation System for Hernia Repair
Devices Surgery FDA
 HSMN NewsFeed - 4 Apr 2014
World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval
Devices Neurology FDA
 HSMN NewsFeed - 1 Apr 2014
Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2014
St. Jude Medical Announces European Launch of Prodigy Spinal Cord Stimulation System with Burst Technology
Devices Neurology Product Launch
 HSMN NewsFeed - 13 Mar 2014
Dolphin Neurostim Receives CE Approval for European Distribution
Devices Neurology Regulatory
 HSMN NewsFeed - 4 Feb 2014
NeuroMetrix Announces Broad SENSUS Distribution Agreement with DJO Global
Devices Distribution
 HSMN NewsFeed - 15 Jan 2014
Competitive Tech's Calmare(R) Pain Device Therapy Garners Favorable Medicare Coverage Judgment
Devices Reimbursement
 HSMN NewsFeed - 13 Jan 2014
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
Biopharmaceuticals Devices Drug Delivery Neurology
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2013
Orexo Announces the Launch of Abstral(R) in Japan
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 11 Dec 2013
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2013
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology
 HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Dec 2013
St. Jude Medical Launches US Study of New Prodigy Neurostimulator to Evaluate Burst Stimulation Technology for Chronic Pain
Devices Neurology
 HSMN NewsFeed - 11 Nov 2013
Horizon Pharma and Mundipharma Sign Exclusive Agreement to Commercialize LODOTRA(R) in the Middle East and Africa
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 8 Oct 2013
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 12 Sep 2013
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
Devices Neurology Personnel
 HSMN NewsFeed - 9 Sep 2013
Assurex Health Appoints Veteran P&G Consumer Products Executive Virginia Coleman Drosos President to Lead Personalized Medicine Growth
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 19 Aug 2013
ACADIA Pharmaceuticals Announces Appointment of Terrence Moore as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Aug 2013
St. Jude Medical Announces Approval and First Use of MediGuide Enabled Ablation Catheters
Devices Cardiology FDA
 HSMN NewsFeed - 12 Aug 2013
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2013
New Medtronic Deep Brain Stimulation System the First to Sense and Record Brain Activity While Delivering Therapy
Devices Neurology
 HSMN NewsFeed - 6 Aug 2013
Medtronic Introduces the First and Only Neurostimulation Systems for Chronic Pain Designed for Full-Body MRI Safety*
Devices Neurology Product Launch
 HSMN NewsFeed - 5 Aug 2013
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim asElite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2013
BioDelivery Sciences Announces Regulatory Approval of ONSOLIS in Taiwan
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 Jul 2013
BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 24 Jun 2013
St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D
Devices Cardiology Regulatory
 HSMN NewsFeed - 4 Jun 2013
St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure
Devices Cardiology Interventional
 HSMN NewsFeed - 23 May 2013
One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology
Devices Cardiology
 HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 May 2013
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2013
St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices
Devices Cardiology Regulatory
 HSMN NewsFeed - 30 Apr 2013
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
Devices Cardiology Regulatory Product Launch
 HSMN NewsFeed - 29 Apr 2013
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2013
Flowonix Medical Inc. Announces US Market Launch of the Prometra(R) Programmable Intrathecal Drug Infusion Pump
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 3 Apr 2013
Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 11 Mar 2013
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2013
St. Jude Medical Announces First Implant in Pivotal Phase of Clinical Trial Evaluating AMPLATZER Cardiac Plug for the Prevention of Stroke in Patients with Atrial Fibrillation
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Feb 2013
Cubist Announces Exclusive Option to Acquire Adynxx
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Feb 2013
Kimberly-Clark Introduces Revolutionary CERVICOOL Cooled Radiofrequencey System for Cervical Joint Pain
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 8 Feb 2013
Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Feb 2013
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 18 Jan 2013
St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention
Devices Cardiology Regulatory
 HSMN NewsFeed - 17 Jan 2013
Collegium Pharmaceutical Announces Relocation to Massachusetts
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2013
Neurodevice Firm SPR(TM) Therapeutics Raises $5M Series A
Devices Neurology Venture Capital
 HSMN NewsFeed - 18 Dec 2012
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Dec 2012
Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 7 Dec 2012
Boston Scientific Receives European Regulatory Approval For New Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology Regulatory
 HSMN NewsFeed - 29 Nov 2012
NeuroMetrix Completes 510(k) Clearance Process for SENSUS(TM) Pain Management System
Devices Endocrinology Neurology FDA
 HSMN NewsFeed - 26 Nov 2012
St. Jude Medical Announces First Transapical Implant of Portico Transcatheter Aortic Heart Valve
Devices Cardiology
 HSMN NewsFeed - 26 Nov 2012
Zogenix Appoints New Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Nov 2012
St. Jude Medical Announces European Approval of the Portico Transcatheter Aortic Heart Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Nov 2012
Abbott Announces First Long-term Patient-reported Health Outcomes Data for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Biopharmaceuticals
 HSMN NewsFeed - 8 Nov 2012
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2012
NeuroMetrix Announces Distribution Agreement with OneSource Medical Group for SENSUS Pain Management Device
Devices Endocrinology Distribution
 HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Oct 2012
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
Biopharmaceuticals
 HSMN NewsFeed - 8 Oct 2012
Neuros Medical Adds Vice President of Clinical and Regulatory Affairs to Management Team
Devices Neurology Personnel
 HSMN NewsFeed - 8 Oct 2012
St. Jude Medical Announces Launch of Its MediGuide Technology
Devices Cardiology
 HSMN NewsFeed - 3 Oct 2012
St. Jude Medical's Peripheral Nerve Stimulation Study Confirms Benefit for Chronic Migraine Patients
Devices
 HSMN NewsFeed - 2 Oct 2012
Mallinckrodt Completes Acquisition of CNS Therapeutics, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2012
St. Jude Medical Receives European CE Mark Approval of Eon Mini Neurostimulator, the World’s Smallest Rechargeable Device to Treat Chronic Migraine
Devices Neurology Regulatory
 HSMN NewsFeed - 30 Aug 2012
St. Jude Medical Realigns Business Units to Support Future Growth Opportunities and Announces Changes to Executive Leadership
Devices Cardiology Neurology Personnel
 HSMN NewsFeed - 28 Aug 2012
Renal Denervation Technology from St. Jude Medical Demonstrates Safe, Rapid and Sustained Reduction in Blood Pressure
Devices Cardiology
 HSMN NewsFeed - 27 Aug 2012
FDA Approves Mallinckrodt’s EXALGO(R) (hydromorphone HCl) Extended-Release Tablets 32 mg (CII) for Opioid-Tolerant Patients with Moderate-to-Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Aug 2012
St. Jude Medical Announces Death of Board Member Thomas H. Garrett
Devices Personnel
 HSMN NewsFeed - 7 Aug 2012
Abbott's Omnilink Elite(R) Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jul 2012
Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 17 Jul 2012
St. Jude Medical Announces Japanese Launch of Industry's First Small Quadripolar Technology to Treat Heart Failure
Devices Cardiology
 HSMN NewsFeed - 16 Jul 2012
St. Jude Medical Announces Initial Findings from Riata Lead Evaluation Study
Devices Cardiology
 HSMN NewsFeed - 10 Jul 2012
First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro’s Chronic Pain Treatment
Devices
 HSMN NewsFeed - 22 Jun 2012
St. Jude Medical Comments on MAUDE Database Report about Durata Lead
Devices Cardiology
 HSMN NewsFeed - 18 Jun 2012
St. Jude Medical Announces FDA Clearance of the AMPLATZER Vascular Plug 4
Devices Interventional FDA
 HSMN NewsFeed - 6 Jun 2012
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Non-radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2012
ORENCIA(R) (abatacept) Demonstrates Comparable Efficacy to Humira(R) (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2012
Orexo acquires US commercial rights of Abstral and ProStrakan acquires the corresponding rights in the EU and rest of the world
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 16 May 2012
Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure
Devices Cardiology
 HSMN NewsFeed - 15 May 2012
St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 May 2012
St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2012
Ampio Pharmaceuticals Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion(TM) for the Treatment of Chronic Pain of Osteoarthritis of the Knee and Schedules May 16th Webcast to Update Shareholders
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2012
St. Jude Medical Announces FDA Approval of Smaller ICD with Physician-Inspired Shape
Devices Cardiology FDA
 HSMN NewsFeed - 8 May 2012
St. Jude Medical Announces FDA Approval of Assura(TM) Implantable Defibrillators with Features that Reduce Inappropriate Shocks
Devices Cardiology FDA
 HSMN NewsFeed - 17 Apr 2012
St. Jude Medical Announces First Implant in Clinical Trial for Accent MRI Pacemaker and Tendril MRI Lead System
Devices Cardiology Radiology
 HSMN NewsFeed - 16 Apr 2012
St. Jude Medical Announces CE Mark Approval of Smaller ICD with Physician-Inspired Shape
Devices Cardiology Regulatory
 HSMN NewsFeed - 7 Apr 2012
St. Jude Medical Seeks Retraction of Heart Rhythm Journal Manuscript by Dr. Robert Hauser
Devices Cardiology
 HSMN NewsFeed - 4 Apr 2012
TONIX Pharmaceuticals Strengthens Management Team with the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Mar 2012
St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 19 Mar 2012
Merz Pharmaceuticals Introduces New Mederma(R) Advanced Scar Gel
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 15 Mar 2012
Medtronic Receives Health Canada License for Deep Brain Stimulation Therapy in Refractory Epilepsy Patients
Devices Neurology Regulatory
 HSMN NewsFeed - 7 Mar 2012
Abbott's Absolute Pro(R) Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 28 Feb 2012
Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Feb 2012
US Patent Office Rejects All Claims in Second MonoSol Patent
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 13 Feb 2012
Medasys Inc. Announces FDA Approval for Implantable Programmable Drug Pump
Devices FDA Drug Delivery
 HSMN NewsFeed - 8 Feb 2012
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 26 Jan 2012
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Hydromorphone
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jan 2012
Jazz Pharmaceuticals plc Announces New Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jan 2012
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jan 2012
Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
Devices Cardiology
 HSMN NewsFeed - 11 Jan 2012
Results of St. Jude Medical’s First Controlled Study of Deep Brain Stimulation Confirms Benefit of Constant Current System for Patients with Parkinson’s Disease
Devices Neurology
 HSMN NewsFeed - 6 Jan 2012
Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 Jan 2012
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 4 Jan 2012
St. Jude Medical Announces Achievement of Stopping Rule and Closing of Patient Enrollment in RESPECT Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Dec 2011
Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2011
St. Jude Medical Announces First Implant in European Clinical Trial Studying Portico Transcatheter Aortic Heart Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2011
Boston Scientific Receives FDA Approval for New Infinion(TM) 16 Percutaneous Lead for Precision Plus(TM) Spinal Cord Stimulator System
Devices Neurology FDA
 HSMN NewsFeed - 8 Dec 2011
Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain
Devices Neurology Regulatory
 HSMN NewsFeed - 17 Nov 2011
Theralase Introduces Low Priced Laser Series
Devices
 HSMN NewsFeed - 15 Nov 2011
Mid Atlantic Spine and Pain Physicians Perform Region’s First Procedure Using New Device from St. Jude Medical
Devices Orthopaedic Neurosurgery Neurology
 HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA
 HSMN NewsFeed - 17 Oct 2011
St. Jude Medical Announces First Use of Renal Denervation Technology
Devices
 HSMN NewsFeed - 26 Sep 2011
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
Devices Neurology FDA
 HSMN NewsFeed - 8 Sep 2011
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia
Devices
 HSMN NewsFeed - 7 Sep 2011
St. Jude Medical Announces European Regulatory Approval of First Implanted Neurostimulation Device to Treat Chronic Migraine
Devices Regulatory
 HSMN NewsFeed - 31 Aug 2011
St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology
Devices Cardiology Monitoring
 HSMN NewsFeed - 31 Aug 2011
Zynex Appoints Vice President of Reimbursement and Billing
Devices Personnel
 HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2011
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices FDA
 HSMN NewsFeed - 11 Jul 2011
St. Jude Medical Receives FDA Approval for Expansion of BROADEN Deep Brain Stimulation Study for Depression
Devices Neurology
 HSMN NewsFeed - 28 Jun 2011
Alternative Pain Therapy for Breast, Prostate and Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jun 2011
St. Jude Medical Reveals Randomized Clinical Trial Data Demonstrating Benefit of Neuromodulation for Chronic Migraine
Devices Neurology
 HSMN NewsFeed - 21 Jun 2011
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
Devices Cardiology Regulatory
 HSMN NewsFeed - 15 Jun 2011
St. Jude Medical Launches Visualization Tool to Improve EP Lab Workflow
Devices Cardiology
 HSMN NewsFeed - 7 Jun 2011
St. Jude Medical Announces First Implant of Portico Transcatheter Heart Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2011
St. Jude Medical Announces Australian Market Launch for First-of-Its-Kind Neurostimulation Lead Delivery System for Chronic Pain
Devices
 HSMN NewsFeed - 20 May 2011
Cost Effectiveness Study Determines FFR Can Improve Health while Reducing Economic Burden in UK, France and Italy
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2011
St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Apr 2011
Diamyd Medical Replaces CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
Horizon Pharma Announces FDA Approval of DUEXIS(R) (ibuprofen/famotidine) for the Relief of the Signs and Symptoms of Rheumatoid Arthritis and Osteoarthritis and to Decrease the Risk of Developing Upper Gastrointestinal Ulcers
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Apr 2011
St. Jude Medical Announces FDA Approval of Trifecta Valve
Devices Cardiology FDA
 HSMN NewsFeed - 18 Apr 2011
St. Jude Medical Announces European Approval of Accent MRI Pacemaker System
Devices Cardiology Regulatory
 HSMN NewsFeed - 14 Apr 2011
St. Jude Medical Announces Approval of ShockGuard(TM) Technology with New DecisionTx(TM) Programming for Unify and Fortify Implantable Defibrillators
Devices Cardiology FDA
 HSMN NewsFeed - 4 Apr 2011
St. Jude Medical Receives FDA Approval for New Bi-Directional Ablation Catheters
Devices Cardiology FDA
 HSMN NewsFeed - 30 Mar 2011
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2011
Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
Devices Neurology Pain Management FDA
 HSMN NewsFeed - 21 Mar 2011
Covidien Announces Interim Data Showing Parietex ProGrip(TM) Self-Fixating Mesh Significantly Reduces Early Pain Following Inguinal Hernia Repair
Devices Surgery
 HSMN NewsFeed - 17 Mar 2011
Elite Announces Settlement of Litigation With ThePharmaNetwork
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 16 Mar 2011
St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant
Devices Cardiology
 HSMN NewsFeed - 9 Mar 2011
Tenex Health Receives FDA Clearance for Innovative TX1(TM) Tissue Removal System
Devices FDA
 HSMN NewsFeed - 14 Feb 2011
ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Feb 2011
Covidien Receives FDA Approval for Fentanyl Transdermal System Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 31 Jan 2011
St. Jude Medical Announces Superior Court Ruling in Trade Secret Lawsuit Involving Its OCT Business and Volcano Corporation and Axsun Technologies
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 25 Jan 2011
St. Jude Medical Earns CE Mark Approval for Manufacturing in Malaysia
Devices Cardiology Regulatory
 HSMN NewsFeed - 24 Jan 2011
St. Jude Medical Announces Australian TGA Approval of Athena Programmer for the Management of Deep Brain Stimulation Therapy
Devices Neurology Regulatory
 HSMN NewsFeed - 20 Jan 2011
St. Jude Medical Reaches Settlement with United States Department of Justice
Devices Litigation
 HSMN NewsFeed - 13 Jan 2011
St. Jude Medical Announces Launch of the ViewMate Z Intracardiac Ultrasound System and ViewFlex Plus ICE Catheter
Devices Cardiology
 HSMN NewsFeed - 6 Jan 2011
Zogenix and Desitin Announce Marketing Approval for SUMAVEL(R) DosePro(TM) in Germany and the United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Dec 2010
Zynex Strengthens Management Team; Adds Regulatory Compliance Expert
Devices Personnel
 HSMN NewsFeed - 16 Dec 2010
St. Jude Medical Launches New Trifecta Valve in Canada
Devices Cardiology
 HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2010
Watson and Richter Announce Exclusive License Agreement for Esmya
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Dec 2010
Pico-Tesla Starts Pilot Study of Magneceutical(R) Therapy For Fibromyalgia
Devices
 HSMN NewsFeed - 9 Dec 2010
Results from CIRSE Multicenter Registry Reinforce Safety of St. Jude Medical Vascular Closure Device
Devices Interventional
 HSMN NewsFeed - 8 Dec 2010
St. Jude Medical Advances Integration of Electrophysiology Lab Equipment with Launch of Several New Technologies
Devices Cardiology
 HSMN NewsFeed - 3 Dec 2010
St. Jude Medical Neurostimulation Study Demonstrates Sustained Improvement in Chronic Low Back Pain Symptoms and Quality of Life
Devices Neurology
 HSMN NewsFeed - 2 Dec 2010
St. Jude Medical Announces New Approvals of Five-Column Neurostimulation Lead to Manage Chronic Pain at 14th Annual North American Neuromodulation Society Meeting
Devices Neurology Regulatory
 HSMN NewsFeed - 30 Nov 2010
Zynex, Inc. Appoints President of Subsidiary, Zynex NeuroDiagnostic
Devices Neurology Personnel
 HSMN NewsFeed - 23 Nov 2010
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen(R) (Baclofen Injection) for the Treatment of Severe Spasticity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Nov 2010
St. Jude Medical Announces Final Results of its Exchange Offer for AGA Medical
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2010
Robert Cozart Promoted to VP of Technical Operations at Zynex
Devices Pain Management Personnel
 HSMN NewsFeed - 18 Nov 2010
St. Jude Medical Announces Completion and Preliminary Results of Exchange Offer for AGA Medical
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2010
St. Jude Medical Announces Development and Marketing Agreement with ZONARE Medical Systems
Devices Cardiology
 HSMN NewsFeed - 15 Nov 2010
St. Jude Medical Announces Results of ASSERT Study Demonstrating Effectiveness of Implantable Device Monitoring in Predicting Stroke
Devices Cardiology Monitoring Neurology
 HSMN NewsFeed - 29 Oct 2010
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 28 Oct 2010
ACADIA Pharmaceuticals Enters Agreement with Biovail to Conclude Collaboration and Regain North American Rights to Pimavanserin
Biopharmaceuticals
 HSMN NewsFeed - 18 Oct 2010
St. Jude Medical and AGA Medical Announce Definitive Agreement
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2010
New Leaf Venture Partners Invests in $35.4 (£22.4) Million Series A Financing of Convergence Pharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Sep 2010
St. Jude Medical Announces Approval of the First Rechargeable Neurostimulator to Manage Chronic Pain in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 21 Sep 2010
St. Jude Medical Announces Results from Angio-Seal Evolution Vascular Closure Device Registry Subset Analysis
Devices Interventional
 HSMN NewsFeed - 8 Sep 2010
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with CardioMEMS
Devices Cardiology Monitoring Venture Capital
 HSMN NewsFeed - 7 Sep 2010
FDA Grants Market Clearance for Erchonia's Zerona Laser
Devices FDA
 HSMN NewsFeed - 7 Sep 2010
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with CardioMEMS
Devices Monitoring Cardiology Venture Capital
 HSMN NewsFeed - 31 Aug 2010
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Aug 2010
BioElectronics Announces New FDA Market Application to Broaden Its Prescription Clearance
Devices Wound Care Surgery FDA
 HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Jul 2010
Boston Scientific Announces FDA Approval of New Leads for the Precision Plus Spinal Cord Stimulator System
Devices Neurology FDA
 HSMN NewsFeed - 29 Jul 2010
Medtronic Launches Novel Clinical Trial Evaluating Spinal Cord Stimulation Therapy for Heart Failure
Devices Cardiology Neurosurgery
 HSMN NewsFeed - 27 Jul 2010
Medtronic's AMPLIFY rhBMP-2 Matrix Receives Positive Votes from FDA Advisory Panel on All Three Key Questions: Safety, Effectiveness and Benefit/Risk
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 27 Jul 2010
St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S.
Devices Cardiology Litigation
 HSMN NewsFeed - 23 Jul 2010
Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA(R) Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 13 Jul 2010
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 12 Jul 2010
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Devices Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 12 Jul 2010
Neuros Medical Adds Neurostimulation Industry Veteran to Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 7 Jul 2010
European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Jun 2010
St. Jude Medical Announces Japanese Approval of the Therapy Cool Path Ablation Catheter
Devices Cardiology Regulatory
 HSMN NewsFeed - 24 Jun 2010
Boston Scientific Announces FDA Approval and Launch of Lead Splitters for the Precision Plus Spinal Cord Stimulator System
Devices FDA
 HSMN NewsFeed - 18 Jun 2010
St. Jude Medical Announces European Approval of Industry's First Flexible Tip Ablation Catheter
Devices Cardiology Regulatory
 HSMN NewsFeed - 17 Jun 2010
St. Jude Medical Announces First Enrollment in Landmark Clinical Trial of Novel Heart Failure Management System
Devices Monitoring Cardiology
 HSMN NewsFeed - 17 Jun 2010
St. Jude Medical Announces European Approval of EnSite Contact Technology Platform
Devices Cardiology Regulatory
 HSMN NewsFeed - 16 Jun 2010
BioElectronics Advances in Its FDA Clearances
Devices FDA
 HSMN NewsFeed - 4 Jun 2010
St. Jude Medical Issues Statement Regarding Settlement with Department of Justice
Devices Cardiology
 HSMN NewsFeed - 27 May 2010
St. Jude Medical Announces European Approval for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices Neurosurgery
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 24 May 2010
Elite Pharmaceuticals Announces Acquisition of Generic Hydromorphone Product
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 13 May 2010
St. Jude Medical Advances Integration of Electrophysiology Lab Equipment with Launch of EnSite Derexi Module
Devices Cardiology FDA
 HSMN NewsFeed - 13 May 2010
FREEDOM Trial Demonstrates CRT Response Rates Using St. Jude Medical Optimization Feature are Comparable to Echo Optimization
Devices Cardiology
 HSMN NewsFeed - 13 May 2010
St. Jude Medical and iRhythm Technologies Enter into Partnership to Co-Market Novel Cardiac Rhythm Monitor
Devices Cardiology Monitoring
 HSMN NewsFeed - 13 May 2010
NicOx provides update on FDA Advisory Committee Meeting for naproxcinod
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2010
St. Jude Medical Announces FDA Approval of Unify CRT-D and Fortify ICD
Devices Cardiology FDA
 HSMN NewsFeed - 11 May 2010
St. Jude Medical Announces European Launch of Industry's First Quadripolar Pacing System
Devices Cardiology
 HSMN NewsFeed - 10 May 2010
Cipher achieves major milestone with FDA approval for CIP-TRAMADOL ER
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2010
Adeona Completes a $17.5 Million Corporate Partnership With Meda AB for the Development and Commercialization of Flupirtine for Fibromyalgia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 May 2010
Meda Acquires Exclusive Rights to flupirtine for fibromyalgia, a Potential USD Billion Indication
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 May 2010
Medtronic Announces Clinical Trial for Breakthrough Technology in Neurostimulation Therapy for Intractable Chronic Pain
Devices Neurology
 HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 3 May 2010
Boston Scientific Begins Groundbreaking Clinical Trial Comparing Spinal Cord Stimulation to Spine Reoperation In Patients With Failed Back Surgery Syndrome
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 27 Apr 2010
BioElectronics Announces Revolutionary Device for Treatment of Chronic Pain
Devices Pain Management
 HSMN NewsFeed - 7 Apr 2010
NeuroTherm Acquires Smith & Nephew Interventional Spine Pain Management Assets
Devices Orthopaedic Interventional Acquisitions
 HSMN NewsFeed - 23 Mar 2010
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for World's Smallest Rechargeable Deep Brain Stimulator for Parkinson's Disease
Devices Regulatory Neurology
 HSMN NewsFeed - 15 Mar 2010
St. Jude Medical Announces Multiple Enhancements to Industry-Leading PressureWire FFR Measurement System
Devices Monitoring Cardiology
 HSMN NewsFeed - 11 Mar 2010
New Introducer Product Line from St. Jude Medical Offers Reliable Access and Facilitates Arterial Closure
Devices Interventional FDA Regulatory
 HSMN NewsFeed - 10 Mar 2010
New Easy-To-Use Knotless Arthroscopic Device Provides Surgeons With Full Control Over Suture Tension; Critical Element In Procedure
Devices Orthopaedic
 HSMN NewsFeed - 10 Mar 2010
Diamyd Medical: Diamyd US Phase III Study Well under Way
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 9 Mar 2010
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Mar 2010
St. Jude Medical Announces Publication of Feasibility Results for Trial of Novel Heart Failure Management System
Devices Cardiology Monitoring
 HSMN NewsFeed - 3 Mar 2010
Bristol-Myers Squibb and Allergan Enter Global Agreement on Investigational Neuropathic Pain Medicine
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2010
St. Jude Medical Receives CE Mark Approval for Trifecta Valve
Devices Cardiology Regulatory
 HSMN NewsFeed - 24 Feb 2010
MicroTransponder Raises $10 Million to Begin Clinical Trials of Wireless Neurostimulation for Chronic Pain and Obtain FDA Clearance
Devices Venture Capital Personnel
 HSMN NewsFeed - 10 Feb 2010
St. Jude Medical Announces European Launch of USB Cellular
Devices Cardiology Regulatory
 HSMN NewsFeed - 4 Feb 2010
St. Jude Medical Announces European Approval of Smaller, Higher Power ICD and CRT-D Devices with New Heart Failure Monitors
Devices Cardiology
 HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2010
St. Jude Medical Announces IRASE AF Clinical Trial to Evaluate Cardiac Ablation Catheter System for Treatment of Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Jan 2010
RCT and Zassi Medical Evolutions Form Leto Medical, LLC
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 19 Jan 2010
St. Jude Medical Achieves Recognition for Security of Patient Data and Completes Successful Testing to Streamline Connection to Patient Medical Records
Devices Monitoring
 HSMN NewsFeed - 18 Jan 2010
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 15 Jan 2010
St. Jude Medical Announces Sponsorship of SCD-HeFT 10-Year Follow-Up Study
Devices Cardiology
 HSMN NewsFeed - 14 Jan 2010
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital
 HSMN NewsFeed - 7 Dec 2009
Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche
Biopharmaceuticals Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 4 Dec 2009
St. Jude Medical Receives FDA Approval for Industry-First Five-Column Neurostimulation Lead to Manage Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 3 Dec 2009
New Neurostimulation Patient Programming Software Enables More Thorough and Efficient Capture of Complex Pain Patterns
Devices FDA
 HSMN NewsFeed - 2 Dec 2009
Elite Pharmaceutics and ThePharmaNetwork Announce FDA Approval for Generic Methadone Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Nov 2009
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic Pain
Devices
 HSMN NewsFeed - 12 Nov 2009
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Nov 2009
Neuros Medical Expands Management Team, Forms Advisory Board
Devices Neurology Personnel
 HSMN NewsFeed - 10 Nov 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2009
Wright Medical Group, Inc. Receives FDA Approval to Market CONSERVE(R) Plus Total Hip Resurfacing System
Devices Orthopaedic FDA
 HSMN NewsFeed - 22 Oct 2009
Zogenix and Astellas Announce Data Published Showing the Benefits of SUMAVEL(TM) DosePro(TM) Needle-Free Delivery System
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 20 Oct 2009
New Data Describe Safety of Subcutaneous Administration of ORENCIA(R) (abatacept) For Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 30 Sep 2009
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Sep 2009
FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Sep 2009
St. Jude Medical Announces FDA Approval of EnSite Velocity Cardiac Mapping System
Devices Cardiology FDA
 HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 9 Sep 2009
St. Jude Medical Receives CE Mark Approval for World's Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson's Disease
Devices Neurology Regulatory
 HSMN NewsFeed - 1 Sep 2009
ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Aug 2009
St. Jude Medical Announces Opening of European Advanced Learning Center For Continuing Physician Education in Heart Disease Therapies
Devices Cardiology
 HSMN NewsFeed - 26 Aug 2009
Updated ORENCIA(R) (abatacept) Labeling Includes Data to Support Earlier Use in Adult Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 5 Aug 2009
Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 3 Aug 2009
Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
Biopharmaceuticals
 HSMN NewsFeed - 28 Jul 2009
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2009
St. Jude Medical Announces FDA Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
Devices Cardiology FDA
 HSMN NewsFeed - 16 Jul 2009
Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy
Devices Neurology FDA
 HSMN NewsFeed - 16 Jul 2009
Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jul 2009
St. Jude Medical Announces Australian TGA Regulatory Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
Devices Neurology Regulatory
 HSMN NewsFeed - 22 Jun 2009
NeuroTherm Completes Acquisition of the Micron Epidural Catheter
Devices Acquisitions
 HSMN NewsFeed - 19 Jun 2009
NeuroTherm Completes Acquisition of the Micron Epidural Catheter
Devices Surgery Acquisitions
 HSMN NewsFeed - 17 Jun 2009
St. Jude Medical Announces FDA Approval of the Cool Point Irrigation Pump
Devices Cardiology FDA
 HSMN NewsFeed - 12 Jun 2009
St. Jude Medical Announces Leading Sponsorship of Landmark Clinical Trial to Study Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 10 Jun 2009
St. Jude Medical Announces Initial Implant of First-to-Market Connector System in the U.S.
Devices Cardiology
 HSMN NewsFeed - 8 Jun 2009
St. Jude Medical Acquires Intellectual Property and Non-Cash Assets of Northstar Neuroscience, Inc.
Devices Neurology Acquisitions
 HSMN NewsFeed - 8 Jun 2009
St. Jude Medical Completes Implants in U.S. Study of Deep Brain Stimulation for Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 2 Jun 2009
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 21 May 2009
NeurogesX Receives European Commission Approval for Qutenza(TM)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 13 May 2009
St. Jude Medical Announces European Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
Devices Cardiology Regulatory
 HSMN NewsFeed - 12 May 2009
DARA BioSciences Announces Positive Trial Results of KRN5500 for Treatment of Neuropathic Pain in Patients With Cancer
Biopharmaceuticals
 HSMN NewsFeed - 12 May 2009
St. Jude Medical Announces European CE Mark Approval and First Use of Next-Generation Cardiac Mapping System
Devices Cardiology Regulatory
 HSMN NewsFeed - 11 May 2009
St. Jude Medical Announces European Approval of Its Newest Heart Failure Devices Which Enable More Efficient Implantation and Follow-up
Devices Cardiology Regulatory
 HSMN NewsFeed - 11 May 2009
St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices to Provide Therapy for Life-Threatening Arrhythmias and Heart Failure
Devices Cardiology FDA
 HSMN NewsFeed - 7 May 2009
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 6 May 2009
St. Jude Medical Announces FDA Clearance and Launch of the Attune Annuloplasty Ring for Heart Valve Repair
Devices Cardiology FDA
 HSMN NewsFeed - 24 Apr 2009
St. Jude Medical Announces CE Mark Approval of Remote Care System for Implantable Cardiac Devices
Devices Cardiology Regulatory
 HSMN NewsFeed - 20 Apr 2009
St. Jude Medical Announces European Approval of ICDs with Features That Automatically Enhance Patient Safety and Streamline Patient Follow-up
Devices Cardiology Regulatory
 HSMN NewsFeed - 15 Apr 2009
TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
Biopharmaceuticals
 HSMN NewsFeed - 1 Apr 2009
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 30 Mar 2009
St. Jude Medical and GE Healthcare Announce Worldwide Market Launch of Wireless Integrated FFR Solution
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
Biopharmaceuticals Pain Management Regulatory
 HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
Devices Neurology Cardiology Regulatory
 HSMN NewsFeed - 9 Mar 2009
Victory Pharma Announces US$45 Million Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Feb 2009
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2009
Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder
Devices Orthopaedic
 HSMN NewsFeed - 24 Feb 2009
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for the World's Smallest and Longest-Lasting Rechargeable Neurostimulator to Treat Chronic Pain
Devices Regulatory
 HSMN NewsFeed - 17 Feb 2009
Cipher receives tentative FDA approval for extended-release tramadol capsules
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 Feb 2009
UT Southwestern Performs First Local Implant in Deep Brain Stimulation Study for Depression
Devices Neurosurgery Neurology
 HSMN NewsFeed - 5 Feb 2009
St. Jude Medical Announces U.S. Approval of Industry's First Connector System Designed to Simplify Implant Process for Cardiac Resynchronization Therapy Devices
Devices Cardiology FDA
 HSMN NewsFeed - 30 Jan 2009
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2009
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jan 2009
St. Jude Medical Announces European CE Mark Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
Devices Neurology Regulatory
 HSMN NewsFeed - 26 Jan 2009
Targin(R) (Oral Oxycodone/Naloxone Prolonged-Release Tablet) now Launching Across Europe to Control Severe Chronic Pain With Significantly Reduced Risk of Opioid-Induced Constipation
Biopharmaceuticals
 HSMN NewsFeed - 15 Jan 2009
St. Jude Medical Announces Publication of 20-year Durability in Aortic and Mitral Stented Tissue Valves
Devices Cardiology
 HSMN NewsFeed - 15 Jan 2009
St. Jude Medical Announces First Use Outside the U.S. of Imaging System for Real-Time Views inside the Heart
Devices Cardiology
 HSMN NewsFeed - 14 Jan 2009
St. Jude Medical Announces Japanese Approval of Atlas II ICD
Devices Cardiology Regulatory
 HSMN NewsFeed - 12 Jan 2009
InSet Technologies Completes $25 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 31 Dec 2008
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
Biopharmaceuticals Drug Delivery Product Recall
 HSMN NewsFeed - 31 Dec 2008
Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 279

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 279 additional stories matching:
chronic pain
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!